Breakthrough therapies, breakthrough economics in the era of cure

Cellular immunotherapies and gene replacement therapies herald new therapeutic categories and renewed discussion of how transformative therapies should be integrated into the US healthcare system. All stakeholders will need to participate in processes focused on long-term healthcare system stewardship.

Please enter your email to access content Read now